Compile Data Set for Download or QSAR
Found 29 with Last Name = 'putta' and Initial = 'vprk'
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 300nMAssay Description:Inhibition of NNMT in human U2OS cells assessed as reduction in MNA production after 24 hrs by LC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 512nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455085(CHEMBL4217817)copy SMILEScopy InChI
Affinity DataIC50: 580nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455092(CHEMBL4218043)copy SMILEScopy InChI
Affinity DataIC50: 588nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455087(CHEMBL4207500)copy SMILEScopy InChI
Affinity DataIC50: 922nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Mus musculus)
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of NNMT in mouse 3T3L1 cells assessed as reduction in MNA production after 24 hrs by LC-MS/MS analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455095(CHEMBL4206972)copy SMILEScopy InChI
Affinity DataIC50: 2.37E+3nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Mus musculus)
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of mouse NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455086(CHEMBL4204179)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455078(CHEMBL4218848)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM228815(5-MeO-PZA)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455088(CHEMBL4206735)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455089(CHEMBL4209022)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455090(CHEMBL4202617)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455091(CHEMBL4216237)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455077(CHEMBL1997189)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455093(CHEBI:27410 | CHEMBL3542314)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455094(CHEMBL4212164)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455097(CHEMBL4205858)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455079(CHEMBL4210945)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50340090(4-methoxybenzamide | CHEMBL449635)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455084(CHEMBL4214098)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455083(CHEMBL4218838)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455080(CHEMBL4207893)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455081(CHEMBL4209724)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed
TargetNicotinamide N-methyltransferase(Homo sapiens (Human))
Sanofi-Aventis Deutschland GmbH

Curated by ChEMBL
LigandPNGBDBM50455082(CHEMBL4215561)copy SMILEScopy InChI
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human NNMT at 30 uM preincubated for 30 mins followed by nicotinamide substrate and SAM addition measured after 60 mins by fluorescence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22Z184CPubMed